New Horizons in Nephrology: Glomerular Disease in 2021: Progress and Potential, From Famine to Feast

LIVECMEConferences & Symposia
New Horizons in Nephrology: Glomerular Disease in 2021: Progress and Potential, From Famine to Feast Banner

Add to Calendar New Horizons in Nephrology: Glomerular Disease in 2021: Progress and Potential, From Famine to Feast 9/10/2021 7:30:00 AM 9/10/2021 4:15:00 PM America/New_York Virtual Meeting false MM/DD/YYYY


Date & Location
Friday, September 10, 2021, 7:30 AM - 4:15 PM EST, Virtual Meeting, Philadelphia , PA

Course Overview
Glomerular disease is associated with morbidity and mortality in patients of all ages and is a common cause of end state kidney disease. These patients include those that commonly present with nephrotic syndrome (minimal change disease, FSGS and membranous nephropathy), the nephrotic syndrome (vasculitis, lupus nephritis and IgA nephropathy), among others. Treatment often utilizes immunosuppressive regimens such as high dose corticosteroids, alkylating agents, calcineurin inhibitors, biologics and antimetabolites, which are associated with significant side effects and morbidity. Thus, glomerular diseases present a difficult and unique challenge to both patients and nephrologists and are associated with high treatment costs and historically, have had poor renal outcomes. There have been significant recent advances in the field in both the diagnosis and treatment of glomerular diseases. Therefore it is essential for physicians to stay current with these new approaches to diagnosing and managing glomerular diseases.

Target Audience
Specialties - INTERNAL MEDICINE - Nephrology


Objectives
  1. Leverage ongoing clinical trials to improve treatment options for IgA nephropathy
  2. Discuss the use of genetic testing in patients with FSGS
  3. Review the complexities of diagnosing tubulointerstitial disease
  4. Discuss recent data on the treatment of lupus nephritis
  5. Explain how recent randomized controlled trials in ANCA associated vasculitis are informing clinical management of this disease
  6. Demonstrate expertise in diagnosing and treating membranous nephropathy in 2021
  7. Employ a culture within the community to reduce practice variability and make strides in improving patient outcomes

Registration
New Horizons in Nephrology: Glomerular Disease in 2021: Progress and Potential, From Famine to Feast will be held on Friday, September 10, 2021 by live-stream only. This conference will follow the scheduled agenda in real time.
 
The registration fee for New Horizons in Nephrology: Glomerular Disease in 2021: Progress and Potential, From Famine to Feast is Feast is $75 for physicians, $50 for nurses, and other healthcare providers. A reduced registration fee of $10 is available for all residents and fellows. The fee includes course registration, live stream access to the conference and access to view presentations (slides) online.
 
All pre-registered attendees will receive a link and instructions that will allow attendees to sign in and participate in the live conference. A credit card will be required for registration. We cannot accept faxed or mailed registration forms at this time. Registrations must be received by September 8, 2021.

Accreditation

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation of Credit
Penn Medicine designates this live activity for a maximum of 7 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Credits
AMA PRA Category 1 Credits™ (7.00 hours), Non-Physician Attendance / Participation (7.00 hours)